Currently held
- Agent 17 — 52-Week High Momentumlong62 sh @ $62.00 · stop —-$115.01 unrealized
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
CYH Completes Sale of Four Arkansas Hospitals for $110M to Lower Debt
Community Health sells four Arkansas hospitals for $110M, extending its asset-sale aimed at boosting liquidity, cutting debt and sharpening its healthcare portfolio.
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
CYH Completes Sale of Four Arkansas Hospitals for $110M to Lower Debt
Community Health sells four Arkansas hospitals for $110M, extending its asset-sale aimed at boosting liquidity, cutting debt and sharpening its healthcare portfolio.
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
CYH Completes Sale of Four Arkansas Hospitals for $110M to Lower Debt
Community Health sells four Arkansas hospitals for $110M, extending its asset-sale aimed at boosting liquidity, cutting debt and sharpening its healthcare portfolio.
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
CYH Completes Sale of Four Arkansas Hospitals for $110M to Lower Debt
Community Health sells four Arkansas hospitals for $110M, extending its asset-sale aimed at boosting liquidity, cutting debt and sharpening its healthcare portfolio.
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Accuity Names Hannah Hartung Chief Operating Officer to Drive Operational Scale and Performance
Accuity, an AI-driven clinical revenue integrity partner for leading health systems, has named Hannah Hartung Chief, Operating Officer. She will lead the company's operational strategy and execution across delivery functions, driving scalable performance as Accuity continues expanding its partnerships with health systems nationwide.
Agent 7 — Day Trader — decide: skip
CNC is down ~1.6% intraday, a moderate but not outsized move. The only recent headline is a generic 'dividend hopefuls' mention with no negative catalyst, so no news is amplifying the move. Macro context shows T10Y2Y at 2σ below trend (flatter/inverted leaning), which is modestly supportive of defensives like managed care — this could act as a mild headwind to further downside continuation. With 305 minutes remaining there is ample time for the move to extend, but also ample time for mean reversion. The managed care/healthcare sector has been under periodic policy pressure, which lends some credibility to sustained selling, but without a specific catalyst the move reads more like routine selling flow than a conviction-driven breakdown. No strong reversal signal is present, but the macro backdrop slightly favors defensives stabilizing. Net assessment: marginal continuation probability — meeting the 0.5 threshold to lean with the existing momentum, but no strong conviction for a sustained push lower into the close.
Agent 7 — Day Trader — day_trade_skipped
CNC is down ~1.6% intraday, a moderate but not outsized move. The only recent headline is a generic 'dividend hopefuls' mention with no negative catalyst, so no news is amplifying the move. Macro context shows T10Y2Y at 2σ below trend (flatter/inverted leaning), which is modestly supportive of defensives like managed care — this could act as a mild headwind to further downside continuation. With 305 minutes remaining there is ample time for the move to extend, but also ample time for mean reversion. The managed care/healthcare sector has been under periodic policy pressure, which lends some credibility to sustained selling, but without a specific catalyst the move reads more like routine selling flow than a conviction-driven breakdown. No strong reversal signal is present, but the macro backdrop slightly favors defensives stabilizing. Net assessment: marginal continuation probability — meeting the 0.5 threshold to lean with the existing momentum, but no strong conviction for a sustained push lower into the close.
Centene, Deckers and 14 Other ‘Dividend Hopefuls’
These large-cap companies could be poised to join the dividend club, based on cash holdings and free-cash flow yield, according to Morgan Stanley.
Centene Corporation (CNC): One of the Premier Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]
Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Best Growth Stocks to Buy for June 1st
PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.
Centene Corp. (NYSE:CNC) Breaks Out with High Technical and Setup Quality Scores
This stock screener identifies breakout candidates by filtering for stocks with a strong uptrend (Technical Rating ≥7) and tight consolidation (Setup Quality ≥7). Centene Corp (CNC) scores an 8 and 9, showing a high-probability setup near resistance.
Agent 7 — Day Trader — decide: skip
CNC is up 1.62% intraday, a modest but real move suggesting some directional flow. There are no news headlines to anchor or explain the move, which is common and not disqualifying. The macro context shows the T10Y3M spread elevated at 1.8σ above trend, which is mildly negative for recession-sensitive sectors like managed care (CNC), as it signals potential economic stress concerns — this creates a slight headwind rather than tailwind. However, the move is relatively contained at under 2%, suggesting it hasn't exhausted itself, and with 255 minutes remaining there is ample time for continuation. No reversal signals are evident from the data provided. The macro headwind from an elevated yield curve spread is a modest dampener but not sufficient to flip the outlook to fade. Overall, this reads as ordinary momentum with no strong reason to expect reversal, warranting a slight lean toward continuation.
Agent 7 — Day Trader — day_trade_skipped
CNC is up 1.62% intraday, a modest but real move suggesting some directional flow. There are no news headlines to anchor or explain the move, which is common and not disqualifying. The macro context shows the T10Y3M spread elevated at 1.8σ above trend, which is mildly negative for recession-sensitive sectors like managed care (CNC), as it signals potential economic stress concerns — this creates a slight headwind rather than tailwind. However, the move is relatively contained at under 2%, suggesting it hasn't exhausted itself, and with 255 minutes remaining there is ample time for continuation. No reversal signals are evident from the data provided. The macro headwind from an elevated yield curve spread is a modest dampener but not sufficient to flip the outlook to fade. Overall, this reads as ordinary momentum with no strong reason to expect reversal, warranting a slight lean toward continuation.
Agent 7 — Day Trader — decide: skip
CNC is up 2.81% intraday with no headline catalyst visible, suggesting institutional flow or sector rotation rather than news-driven speculation. The move is meaningful but not extreme. Macro context shows T10Y3M at 1.8σ above trend, which is mildly supportive for recession-sensitive sectors like managed care (CNC), as a steeper curve can signal improving economic outlook reducing near-term healthcare utilization headwinds. However, with 380 minutes remaining (essentially a full remaining session), there is ample time for both continuation and reversal. No news to anchor the thesis creates some uncertainty about whether the catalyst is durable. The absence of a clear fade pattern and the magnitude of the move (real conviction flow) support modest continuation probability. No strong reversal signals present, so defaulting to mild continuation bias consistent with momentum persistence in mid-session moves of this size.
Agent 7 — Day Trader — day_trade_skipped
CNC is up 2.81% intraday with no headline catalyst visible, suggesting institutional flow or sector rotation rather than news-driven speculation. The move is meaningful but not extreme. Macro context shows T10Y3M at 1.8σ above trend, which is mildly supportive for recession-sensitive sectors like managed care (CNC), as a steeper curve can signal improving economic outlook reducing near-term healthcare utilization headwinds. However, with 380 minutes remaining (essentially a full remaining session), there is ample time for both continuation and reversal. No news to anchor the thesis creates some uncertainty about whether the catalyst is durable. The absence of a clear fade pattern and the magnitude of the move (real conviction flow) support modest continuation probability. No strong reversal signals present, so defaulting to mild continuation bias consistent with momentum persistence in mid-session moves of this size.
Agent 7 — Day Trader — decide: skip
CNC is up ~1.96% intraday with no attributable news catalyst, suggesting this is flow/technical-driven rather than fundamental. The move is meaningful but sits at the lower boundary of the 2-5% high-conviction range. Macro context shows an elevated T10Y3M spread (0.82, 1.9σ above trend), which is modestly positive for the yield curve normalization narrative but CNC as a managed care/healthcare name is not a primary beneficiary of yield curve steepening — it is recession-sensitive, meaning the macro backdrop is neutral-to-mildly supportive rather than a strong tailwind. With 150 minutes remaining there is ample time for continuation, which is a positive factor. However, the absence of any news headline leaves the move's catalyst unclear, and managed care names can be prone to intraday fades when moves lack a clear driver. No reversal pattern is evident from the data provided. On balance, momentum is modestly intact with time on its side, but the lack of a clear catalyst and the sector's limited macro alignment cap conviction. Assigning a slight continuation edge above 0.5.
Agent 7 — Day Trader — day_trade_skipped
CNC is up ~1.96% intraday with no attributable news catalyst, suggesting this is flow/technical-driven rather than fundamental. The move is meaningful but sits at the lower boundary of the 2-5% high-conviction range. Macro context shows an elevated T10Y3M spread (0.82, 1.9σ above trend), which is modestly positive for the yield curve normalization narrative but CNC as a managed care/healthcare name is not a primary beneficiary of yield curve steepening — it is recession-sensitive, meaning the macro backdrop is neutral-to-mildly supportive rather than a strong tailwind. With 150 minutes remaining there is ample time for continuation, which is a positive factor. However, the absence of any news headline leaves the move's catalyst unclear, and managed care names can be prone to intraday fades when moves lack a clear driver. No reversal pattern is evident from the data provided. On balance, momentum is modestly intact with time on its side, but the lack of a clear catalyst and the sector's limited macro alignment cap conviction. Assigning a slight continuation edge above 0.5.
Agent 7 — Day Trader — decide: skip
CNC is up 2.37% intraday with no headline catalyst identified, suggesting this is likely flow/positioning-driven rather than news-driven. The move is meaningful and represents real buying conviction. However, several factors temper the continuation outlook: (1) With 384 minutes remaining (~6.4 hours), this appears to be very early in the session, meaning there is ample time for the move to both run further or fully reverse — early-session moves without catalysts can fade as the day progresses and initial momentum exhausts. (2) The macro backdrop (T10Y2Y at 1.9σ below 24-month trend, a flattening/slightly inverted curve environment) is modestly supportive for defensive/managed care names like CNC, as investors may rotate toward defensives in a bear-flattening regime. (3) No news is present, which per framework is not a disqualifier. (4) CNC is a managed care / healthcare services name — not a direct bank, so the macro read is neutral-to-mildly supportive. Overall, momentum is real but not exceptional, macro is mildly supportive, and time is ample for further drift. Assigning a modest continuation probability just above the 0.5 threshold, consistent with ordinary momentum with no strong reason to expect immediate fade.
Agent 7 — Day Trader — day_trade_skipped
CNC is up 2.37% intraday with no headline catalyst identified, suggesting this is likely flow/positioning-driven rather than news-driven. The move is meaningful and represents real buying conviction. However, several factors temper the continuation outlook: (1) With 384 minutes remaining (~6.4 hours), this appears to be very early in the session, meaning there is ample time for the move to both run further or fully reverse — early-session moves without catalysts can fade as the day progresses and initial momentum exhausts. (2) The macro backdrop (T10Y2Y at 1.9σ below 24-month trend, a flattening/slightly inverted curve environment) is modestly supportive for defensive/managed care names like CNC, as investors may rotate toward defensives in a bear-flattening regime. (3) No news is present, which per framework is not a disqualifier. (4) CNC is a managed care / healthcare services name — not a direct bank, so the macro read is neutral-to-mildly supportive. Overall, momentum is real but not exceptional, macro is mildly supportive, and time is ample for further drift. Assigning a modest continuation probability just above the 0.5 threshold, consistent with ordinary momentum with no strong reason to expect immediate fade.
Agent 7 — Day Trader — decide: skip
CNC is up 1.62% today, a modest but real move suggesting some buying conviction. There are no headlines to explain the move, which is common — absence of news doesn't disqualify continuation. However, the macro context is mildly cautionary: the T10Y3M spread is elevated at 2.2σ above trend, which tends to weigh on recession-sensitive sectors like managed care/health insurers (CNC's category), as it signals tighter financial conditions and potential demand headwinds. The move is below the 2% threshold that would indicate strong institutional flow, and with 250 minutes remaining there is ample time for either continuation or fade. No reversal signals are present, and the move is not overextended. On balance, the setup is mildly favorable for continuation — ordinary momentum with no strong reason to fade — but the macro backdrop provides a mild headwind. Probability set just above the 0.5 threshold reflecting a lean toward continuation without strong conviction.
Agent 7 — Day Trader — day_trade_skipped
CNC is up 1.62% today, a modest but real move suggesting some buying conviction. There are no headlines to explain the move, which is common — absence of news doesn't disqualify continuation. However, the macro context is mildly cautionary: the T10Y3M spread is elevated at 2.2σ above trend, which tends to weigh on recession-sensitive sectors like managed care/health insurers (CNC's category), as it signals tighter financial conditions and potential demand headwinds. The move is below the 2% threshold that would indicate strong institutional flow, and with 250 minutes remaining there is ample time for either continuation or fade. No reversal signals are present, and the move is not overextended. On balance, the setup is mildly favorable for continuation — ordinary momentum with no strong reason to fade — but the macro backdrop provides a mild headwind. Probability set just above the 0.5 threshold reflecting a lean toward continuation without strong conviction.
Agent 6 — Options Momentum closed long 200 @ $3.06 (-$230.54)
Stop: premium $3.06 ≤ trailing floor $3.16 (peak $4.21 × 0.75)
Agent 7 — Day Trader — decide: skip
CNC is up 1.56% today, a modest but real move suggesting some directional flow. However, several factors temper conviction: (1) No news catalyst is present to explain the move or sustain momentum into the close. (2) The macro context shows 10-year inflation expectations (T10YIE) running 2.4σ above trend, which creates pressure on long-duration sensitive sectors; managed care/health insurance like CNC is not a primary rate-sensitive sector, so macro headwind is limited but not entirely absent. (3) With only 75 minutes remaining, there is modest but not ample time for the move to extend to the +3% target — the stock would need to reach ~$59.98 from $59.14, requiring roughly another 1.4% gain. (4) The move magnitude at 1.56% is below the 2-5% 'strong conviction' threshold, suggesting this may be ordinary drift rather than a powerful momentum event. On balance, no clear reversal signal is present, volume context is unknown, and the system's bounded risk profile supports taking the marginal trade. Probability set at floor threshold reflecting neutral-to-slightly-positive continuation odds.
Agent 7 — Day Trader — day_trade_skipped
CNC is up 1.56% today, a modest but real move suggesting some directional flow. However, several factors temper conviction: (1) No news catalyst is present to explain the move or sustain momentum into the close. (2) The macro context shows 10-year inflation expectations (T10YIE) running 2.4σ above trend, which creates pressure on long-duration sensitive sectors; managed care/health insurance like CNC is not a primary rate-sensitive sector, so macro headwind is limited but not entirely absent. (3) With only 75 minutes remaining, there is modest but not ample time for the move to extend to the +3% target — the stock would need to reach ~$59.98 from $59.14, requiring roughly another 1.4% gain. (4) The move magnitude at 1.56% is below the 2-5% 'strong conviction' threshold, suggesting this may be ordinary drift rather than a powerful momentum event. On balance, no clear reversal signal is present, volume context is unknown, and the system's bounded risk profile supports taking the marginal trade. Probability set at floor threshold reflecting neutral-to-slightly-positive continuation odds.
Agent 6 — Options Momentum — decide: buy
CALL on CNC — 5-day return 7.68% with close above 20-day MA ($49.90). IV 59.4%. Sized 2 contract(s) at $4.21 premium.
Agent 6 — Options Momentum opened long 200 @ $4.21